AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11322841 — intervention group
Group type: COMPARATOR
Intervention: Wait list control (subsequently treated)
Number of subjects: 60
Study 11322841 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sample (after treatment for wait list control)
Number of subjects: 60
Study 9032045 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (80 parts per million)
Number of subjects: 58
Study 9032045 — intervention group
Group type: COMPARATOR
Intervention: Control gas (nitrogen)
Number of subjects: 58
Study 8302530 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day of lovastatin
Number of subjects: 192
Study 8302530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 3558996 — intervention group
Group type: EXPERIMENTAL
Intervention: Azatadine (topical tricyclic antihistamine)
Number of subjects: 0
Study 3558996 — intervention group
Group type: COMPARATOR
Intervention: Cold, dry air (CDA) challenge
Number of subjects: 0
Study 29631804 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 608
Study 29631804 — intervention group
Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 608
Study 29631804 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline aortic-root SI (>9.1) and elastic modulus (EM >618 mm Hg)
Number of subjects: 608
Study 29631804 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-quartile aortic-root EM (>914 mm Hg)
Number of subjects: 608
Study 29631804 — intervention group
Group type: COMPARATOR
Intervention: Higher EM groups
Number of subjects: 608
Study 27602906 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) 120 mg/kg over 1 hour
Number of subjects: 3
Study 25395386 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive educational intervention with electronic reminders tailored to weather conditions, sent every 2 weeks by text message or email.
Number of subjects: 101
Study 25395386 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group).
Number of subjects: 101
Study 25395386 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive educational intervention.
Number of subjects: 101
Study 22310513 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training for 4 weeks, 30 seconds at 35 Hz for the first 2 weeks, 40 seconds at 40 Hz for the final 2 weeks
Number of subjects: 17
Study 22310513 — intervention group
Group type: COMPARATOR
Intervention: Control group performing the same exercises without vibration stimulation
Number of subjects: 17
Study 21495269 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcigard‐10 softgel
Number of subjects: 0
Study 21495269 — intervention group
Group type: COMPARATOR
Intervention: Adalat 10 capsule
Number of subjects: 0
Study 18594093 — intervention group
Group type: EXPERIMENTAL
Intervention: Polished cemented femoral component (Ra, 0.18 to 0.3 microm)
Number of subjects: 201
Study 18594093 — intervention group
Group type: COMPARATOR
Intervention: Precoated roughened cemented femoral component (Ra, 1.8 to 2.3 microm)
Number of subjects: 201
Study 18594093 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Polished and Precoated roughened)
Number of subjects: 201
Study 16109780 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 2726
Study 16109780 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin (LMWH)
Number of subjects: 2726
Study 12486418 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril treatment
Number of subjects: 6797
Study 12486418 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejection fraction
Number of subjects: 6797
Study 12486418 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejection fraction scaled into tertiles
Number of subjects: 6797
Study 12486418 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial baseline risk
Number of subjects: 6797
Study 10399791 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated Gal(0)corr in SPA patients
Number of subjects: 47
Study 10399791 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated Gal(0)corr at 6-month follow-up
Number of subjects: 47
Study 10399791 — intervention group
Group type: EXPERIMENTAL
Intervention: Gal(0)corr levels
Number of subjects: 47
Study 7673104 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 99
Study 7673104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 1639046 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual dietary counselling aimed at reducing dietary fat intake to 20‐25% energy (E%)
Number of subjects: 240
Study 1639046 — intervention group
Group type: COMPARATOR
Intervention: No dietary advice
Number of subjects: 240
Study 6492017 — intervention group
Group type: EXPERIMENTAL
Intervention: High stress/common fate
Number of subjects: 60
Study 6492017 — intervention group
Group type: EXPERIMENTAL
Intervention: High stress/dissimilar fate
Number of subjects: 60
Study 6492017 — intervention group
Group type: EXPERIMENTAL
Intervention: Low stress/common fate
Number of subjects: 60
Study 6492017 — intervention group
Group type: EXPERIMENTAL
Intervention: Low stress/dissimilar fate
Number of subjects: 60
Study 30910304 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine bathing
Number of subjects: 0
Study 30910304 — intervention group
Group type: COMPARATOR
Intervention: Routine bathing
Number of subjects: 0
Study 30575473 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 695
Study 30575473 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 695
Study 25411039 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MNs) + fish oil (FO)
Number of subjects: 230
Study 25411039 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MNs)
Number of subjects: 230
Study 25411039 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 230
Study 22850606 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg orally after radiotracer injection
Number of subjects: 211
Study 22850606 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pharmacological intervention)
Number of subjects: 211
Study 19960970 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginsenosides (GS) Capsule (50 mg) twice daily
Number of subjects: 60
Study 19960970 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule of equal dosage
Number of subjects: 60
Study 17898981 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS) added to Topiramate (TPM)
Number of subjects: 19
Study 15147434 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (40-80 mg/day)
Number of subjects: 2102
Study 15147434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2102
Study 11585356 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of retinyl palmitate
Number of subjects: 9
Study 11585356 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 microg of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]
Number of subjects: 9
Study 11585356 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of retinyl palmitate plus 2 microg of 1,25(OH)2D3
Number of subjects: 9
Study 11585356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 9572322 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 1456
Study 9572322 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg once daily
Number of subjects: 1456
Study 9572322 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 1456
Study 9572322 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol 200 microg four times daily
Number of subjects: 1456
Study 7837406 — intervention group
Group type: EXPERIMENTAL
Intervention: DFK group (total intravenous anesthesia with droperidol, fentanyl and ketamine)
Number of subjects: 35
Study 7837406 — intervention group
Group type: COMPARATOR
Intervention: Enflurane group (enflurane‐N2O)
Number of subjects: 35
Study 7837406 — intervention group
Group type: COMPARATOR
Intervention: NLA group (neuroleptic anesthesia with droperidol, pentazocine‐N2O)
Number of subjects: 35
Study 3280587 — intervention group
Group type: EXPERIMENTAL
Intervention: Total body calcium by neutron activation analysis (TBC)
Number of subjects: 122
Study 3280587 — intervention group
Group type: EXPERIMENTAL
Intervention: Single photon absorptiometry at the radius (SPA)
Number of subjects: 122
Study 3280587 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual photon absorptiometry at the spine (DPA)
Number of subjects: 122
Study 3280587 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative computed tomography of the spine (QCT)
Number of subjects: 122
Study 3280587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancellous bone volume from iliac crest bone biopsies
Number of subjects: 122
Study 3280587 — intervention group
Group type: EXPERIMENTAL
Intervention: Height loss
Number of subjects: 122
Study 3280587 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone mass index defined using z scores from SPA, DPA, QCT, and TBC measurements
Number of subjects: 122
Study 31944474 — intervention group
Group type: EXPERIMENTAL
Intervention: LOGBI
Number of subjects: 125
Study 31944474 — intervention group
Group type: EXPERIMENTAL
Intervention: DPGBI
Number of subjects: 125
Study 28340091 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 319
Study 28340091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study 28340091 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrence of AOM during follow-up
Number of subjects: 319
Study 28340091 — intervention group
Group type: COMPARATOR
Intervention: No recurrence of AOM during follow-up
Number of subjects: 319
Study 27133392 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative vignettes in newsletters
Number of subjects: 21526
Study 27133392 — intervention group
Group type: COMPARATOR
Intervention: Control newsletters with descriptive text
Number of subjects: 21526
Study 27018027 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (Ibuprofen + amoxicillin, clavulanic acid)
Number of subjects: 129
Study 27018027 — intervention group
Group type: COMPARATOR
Intervention: Group A (Ibuprofen only)
Number of subjects: 129
Study 23703896 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (4000 IU/day, subcutaneously for 48 weeks)
Number of subjects: 70
Study 23703896 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 70
Study 20575711 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy suspension for 1 or 2 months before the next screening mammogram.
Number of subjects: 881
Study 19106467 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: sandblasting with 50‐microm aluminum oxide and 37% phosphoric acid etching (PA)
Number of subjects: 3
Study 19106467 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: bur roughening and etching with 37% PA
Number of subjects: 3
Study 19106467 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3: etching with 37% PA only
Number of subjects: 3
Study 19106467 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradia Direct (GD)
Number of subjects: 3
Study 19106467 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradia (G)
Number of subjects: 3
Study 19106467 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradia Forte (GF)
Number of subjects: 3
Study 16870057 — intervention group
Group type: EXPERIMENTAL
Intervention: Actor prototypes
Number of subjects: 247
Study 16870057 — intervention group
Group type: COMPARATOR
Intervention: Abstainer prototypes
Number of subjects: 247
Study 16870057 — intervention group
Group type: EXPERIMENTAL
Intervention: PWM variables
Number of subjects: 247
Study 16870057 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived similarity to prototypes
Number of subjects: 247
Study 14960214 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted training programme (the TERM model)
Number of subjects: 43
Study 14960214 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 43
Study 11094363 — intervention group
Group type: EXPERIMENTAL
Intervention: Clark Twin‐block appliance for 6 months
Number of subjects: 40
Study 11094363 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 40
Study 8637789 — intervention group
Group type: EXPERIMENTAL
Intervention: Biweekly schedule of 1.2 million U intramuscular benzathine penicillin G (BPG)
Number of subjects: 360
Study 8637789 — intervention group
Group type: COMPARATOR
Intervention: 4-week schedule of 1.2 million U intramuscular benzathine penicillin G (BPG)
Number of subjects: 360
Study 8637789 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally manufactured BPG brand (4-week schedule)
Number of subjects: 360
Study 8637789 — intervention group
Group type: EXPERIMENTAL
Intervention: Imported BPG brand (4-week schedule)
Number of subjects: 360
Study 1519396 — intervention group
Group type: EXPERIMENTAL
Intervention: Ender-nails
Number of subjects: 100
Study 1519396 — intervention group
Group type: COMPARATOR
Intervention: Dynamic hip screws
Number of subjects: 100
Study 3886600 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 40
Study 3886600 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserine
Number of subjects: 40
Study 3886600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31125274 — intervention group
Group type: EXPERIMENTAL
Intervention: Brigatinib treatment
Number of subjects: 208
Study 28371789 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel classification approach based on nonlinear model identification framework
Number of subjects: 0
Study 28371789 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance correlation filtering as a preprocessing technique
Number of subjects: 0
Study 28371789 — intervention group
Group type: COMPARATOR
Intervention: Comparison with other well-known FS and classification methods
Number of subjects: 0
Study 26892777 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir plus didanosine-EC plus emtricitabine
Number of subjects: 84
Study 25193555 — intervention group
Group type: EXPERIMENTAL
Intervention: Two weeks of immobilization followed by six weeks of supervised cycle training
Number of subjects: 32
Study 25193555 — intervention group
Group type: EXPERIMENTAL
Intervention: Two weeks of immobilization
Number of subjects: 32
Study 25193555 — intervention group
Group type: EXPERIMENTAL
Intervention: Six weeks of supervised cycle training
Number of subjects: 32
Study 25193555 — intervention group
Group type: COMPARATOR
Intervention: Young men
Number of subjects: 32
Study 25193555 — intervention group
Group type: COMPARATOR
Intervention: Elderly men
Number of subjects: 32
Study 22418005 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary sacral nerve stimulation (SNS)
Number of subjects: 14
Study 19997004 — intervention group
Group type: EXPERIMENTAL
Intervention: VMO motor control retraining (MCR)
Number of subjects: 60
Study 19997004 — intervention group
Group type: COMPARATOR
Intervention: Quadriceps strengthening (QS)
Number of subjects: 60
Study 19997004 — intervention group
Group type: COMPARATOR
Intervention: Both MCR and QS
Number of subjects: 60
Study 17666608 — intervention group
Group type: EXPERIMENTAL
Intervention: Group prenatal care
Number of subjects: 1047
Study 17666608 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1047
Study 16272960 — intervention group
Group type: EXPERIMENTAL
Intervention: GW320659 (15 mg/day)
Number of subjects: 191
Study 16272960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study 11862132 — intervention group
Group type: EXPERIMENTAL
Intervention: Cola drink
Number of subjects: 30
Study 11862132 — intervention group
Group type: EXPERIMENTAL
Intervention: Chocolate milk (CM)
Number of subjects: 30
Study 11862132 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice (OJ)
Number of subjects: 30
Study 11862132 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 30
Study 10197321 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumarin 90 mg/day (Group A)
Number of subjects: 77
Study 10197321 — intervention group
Group type: EXPERIMENTAL
Intervention: Coumarin 135 mg/day (Group B)
Number of subjects: 77
Study 8657434 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 60 mg/ml
Number of subjects: 30
Study 8657434 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 4.5 mg/ml
Number of subjects: 30
Study 8657434 — intervention group
Group type: EXPERIMENTAL
Intervention: Salicylic acid (SA) 60 mg/ml
Number of subjects: 30
Study 8657434 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 30
Study 8657434 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) and Salicylic acid (SA) with higher flow rate of acid buffer
Number of subjects: 30
Study 2182235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anistreplase (Eminase)
Number of subjects: 240
Study 2182235 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary streptokinase
Number of subjects: 240
Study 2182235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anistreplase (Eminase) and Intracoronary streptokinase
Number of subjects: 240
Study 114042 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-lactose milk (500 ml twice daily for 1 month)
Number of subjects: 31
Study 114042 — intervention group
Group type: COMPARATOR
Intervention: Unmodified milk (same volume as low-lactose milk during double-blind tests)
Number of subjects: 31
Study 31147363 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (12-week program)
Number of subjects: 180
Study 31147363 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise (comparison group)
Number of subjects: 180
Study 31147363 — intervention group
Group type: COMPARATOR
Intervention: Non-active wait-list control (comparison group)
Number of subjects: 180
Study 28925468 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin plus Paclitaxel plus Bevacizumab (CPB)
Number of subjects: 102
Study 28925468 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin plus Paclitaxel (CP)
Number of subjects: 102
Study 25556539 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%, 20 mL
Number of subjects: 46
Study 25556539 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline, 20 mL
Number of subjects: 46
Study 24144222 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised magnesium sulphate (MgSO4) 151 mg
Number of subjects: 508
Study 24144222 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (placebo)
Number of subjects: 508
Study 20350170 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroencephalographic activities recorded during speech production monitoring experiments.
Number of subjects: 0
Study 19189997 — intervention group
Group type: EXPERIMENTAL
Intervention: Apligraf
Number of subjects: 72
Study 19189997 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 72
Study 16752282 — intervention group
Group type: EXPERIMENTAL
Intervention: Porous‐coated press‐fit cup with ceramic coating (Trilogy, uncemented)
Number of subjects: 90
Study 16752282 — intervention group
Group type: COMPARATOR
Intervention: Acrylic cement with gentamicin (Palacos)
Number of subjects: 90
Study 16752282 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrylic bone cement with fluoride (Cemex‐F)
Number of subjects: 90
Study 15129701 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG PET
Number of subjects: 55
Study 15129701 — intervention group
Group type: COMPARATOR
Intervention: SLL
Number of subjects: 55
Study 15129701 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative FDG PET
Number of subjects: 55
Study 15129701 — intervention group
Group type: COMPARATOR
Intervention: Negative SLL
Number of subjects: 55
Study 11435682 — intervention group
Group type: EXPERIMENTAL
Intervention: Lying on the left side
Number of subjects: 129
Study 11435682 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting in a chair
Number of subjects: 129
Study 9052578 — intervention group
Group type: COMPARATOR
Intervention: Educational information about osteoporosis and a voucher for a bone mineral density test 12 months later
Number of subjects: 140
Study 9052578 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational information plus an immediate dual‐energy x‐ray absorptiometry test for bone mineral density
Number of subjects: 140
Study 9052578 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone mineral density test results (osteopenic or osteoporotic)
Number of subjects: 140
Study 8359600 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflotron (desk-top analyser)
Number of subjects: 0
Study 8359600 — intervention group
Group type: COMPARATOR
Intervention: Control group (no desk-top analyser)
Number of subjects: 0
Study 8359600 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 3459390 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem coadministered with cilastatin (1 g of imipenem and equal amounts of cilastatin)
Number of subjects: 6
Study 3459390 — intervention group
Group type: COMPARATOR
Intervention: Moxalactam (2 g)
Number of subjects: 6
Study 31934593 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-nurse-led multidisciplinary team management for 2 years
Number of subjects: 179
Study 31934593 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 179
Study 30003514 — intervention group
Group type: EXPERIMENTAL
Intervention: Paediatric rotary files Kedo-S
Number of subjects: 60
Study 30003514 — intervention group
Group type: COMPARATOR
Intervention: Hand K-files (Control)
Number of subjects: 60
Study 26244417 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) as an adjunct to Light Therapy (LT) for four weeks after two weeks of LT.
Number of subjects: 0
Study 26244417 — intervention group
Group type: COMPARATOR
Intervention: No Treatment (NT) after two weeks of Light Therapy (LT).
Number of subjects: 0
Study 24560179 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 60
Study 24560179 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 60
Study 22525670 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive cortical stimulation therapy
Number of subjects: 69